43ème Symposium "Hormones and Cell Regulation"
European Society of Endocrinology (ESE)

 

The brain – gut – microbiome network in metabolic regulation and dysregulation

 

Programme préliminaire

 

Mercredi 10 Octobre

 

15:00 – 16.00  Arrivés du bus et  lunch

 

16:00 – 16:10  Bienvenue

 

16:10 – 18:10  Cross-talk between the gut and the brain in metabolic regulation

 

16:10 – 16:50  Jarrad M.Scarlett, University of Washington. Seattle, USA

                       Role of the brain in the pathogenesis of obesity, insulin resistance and type 2 diabetes.

 

16:50 – 17:30  Marion Soto, LNC Therapeutics, Bordeaux, France

                        The brain-gut-microbiome connection in metabolism.

 

17:30 – 18:10  Amandine Everard, UCL, Brussels, Belgium

                       Cross- talk between the gut microbiota and the brain during metabolic disorders.

 

18:10 – 18:50  Vassilis Pachnis, Francis Crick Institute, London, UK

                       Control of the gastrointestinal tract by the enteric neuronal system.

 

19:00 – 20:30  Dîner

 

20:30 – 21:30  Keynote Lecture

                       Jens Juul Holst, University of Copenhagen, Denmark

                       The endocrine function of the gut.

 

21:30  Posters, vin/bière

 

 

Jeudi 11 Octobre

 

8:30 – 13:00   The gut microbiota: a complex ecosystem and its interaction with host cells

 

8:30 – 9:10  Colin Hill, University College Cork, Ireland

                    Overview of gut microorganisms and their implication in shaping host metabolism.

 

9:10 – 9:50  Oluf B. Pedersen, University of Copenhagen, Denmark

                    Human gut microbes impact host serum metabolome and insulin sensitivity.

 

9:50 – 10:30  Eran Elinav, Weizmann Institute, Jerusalem, Israel

                      Environmental, nutritional and endogenous modulation of the microbiota.

 

 

10:30 – 11:00  break café

 

11:00 – 11:40  Siegfried Ussar, Helmholtz Diabetes Center, München, Germany

                      Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome.

 

11:40 – 12:20  Peter Holzer, University of Graz, Austria

                     Gut – brain – microbiome interactions in obesity and depression.

 

12:20 – 13:00  Two short talks from abstracts.

 

13:00 – 14:30   Lunch

 

14:30 – 16:30   Walk around Mt Ste Odile

 

16:30 – 19:10   New mediators/targets in gut function

 

16:30 – 17:10  Bart Staels, Institut Pasteur, Lille, France

                        Bile acids as metabolic regulators of endocrine function and energy metabolism.

 

17:10 – 17:50  Ellen Blaak, Maastricht University, The Netherlands

                       Short chain fatty acids as mediators of host energy metabolism.

 

17:50 – 18:30  Gilles Mithieux, INSERM, Lyon, France

                       Regulation of intestinal gluconeogenesis: which consequences for neuroendocrine function and
                       energy metabolism?

 

 18:30 – 20:00  Dîner

 

20:00 – 21:00  Keynote lecture   

                       Karin Clément, Pitié-Salpëtrière, Paris, France

                       Organ cross-talk in the pathophysiology of obesity

 

 

21:00  Posters, vin/bière

 

Vendredi 12 Octobre

 

8:30 - 12:30  The gut microbiome in metabolic regulation and dysregulation across lifespan

 

8:30 – 9:10  Herbert Tilg, Medical University, Innsbrück, Austria

                   Gut dysfunction and non-alcoholic fatty liver

 

9:10 – 9:50  Louise Olofsson, Salghrenska Academy, University of Göteborg, Sweden

                    Mechanistic studies of the impact of the gut microbiome on obesity and type 2 diabetes.

 

9:50 – 10:30  Remy Burcelin, INSERM, Paul Sabatier University, Toulouse, France.

                     Gut barrier and bacterial translocation in metabolic diseases.

 

 10:30 – 11:00  break café

 

11:00 – 11:40  Joël Doré, Metagenopolis, INRA, Paris, France

                      Do metagenomics approaches in cohorts support a key role for gut microbiome in metabolic diseases?

 

11:40 – 12:20  Two short talks selected from abstracts

 

12:30 – 14:00   Lunch

 

14:00 - 14:40  Patrizia Brigidi, University of Bologna, Italy

                      The gut microbiota of centenarians: signatures of longevity in the gut microbiota profiles.

 

14:40 – 18:00  The gut microbiome  and CNS dysfunction

 

14:40 – 15:20  Tristan Bolmont, Stemedica International, Lausanne, Switzerland

                       Gut microbiota alterations in Alzheimer’s disease: from preclinics to clinical studies.

 

 

15:20 – 15:50  break café

 

15:50 – 16:30  Sylvie Claeysen, INSERM U661, University of Montpellier, France

                       Microbiota influence on Alzheimer’s development

 

16:30 – 17:10  Helen Vuong, UCLA, Los Angeles, USA

                       Maternal microbiome and neurodevelopment.

 

17:10 – 17:40  John Cryan, University College Cork, Ireland

                      Gut-brain axis revisited: which role for the gut microbiota in mood and depression?

 

17:40 – 18:00 Short talk selected from abstracts.

 

18:00 – 19:00 Keynote lecture

                    Emrah Altindis, Joslin Diabetes Center, Boston, USA

                    Viral insulin like peptides activate insulin and IGF-I receptor signalling: a paradigm shift in host microbe interactions.

 

 

19:00 – 21:00 Dégustation de vins et Dîner de gala

 

21:00  Posters, vin/bière

 

Samedi 13 Octobre

 

9:00 – 11:40  Therapeutic perspectives

 

9:00 – 9:40   Filipe Cabreiro, UCL, London, UK

                     Effects of drug-nutrient-microbe interactions on host physiology and lifespan.

 

9:40 – 10:20  Nathalie Delzenne, UCL, Brussels, Belgium

                     Feeding the gut microbiota with prebiotic dietary fibers: therapeutic interest in metabolic disorders.

 

 

10:20 – 10:50  Coffee break

 

10:50 – 11:30   Max Nieuwdorp, Akademisch Medisch Centrum, University of Amsterdam, The Netherlands

                     Gut microbial transfer from healthy to diseased (T2D) individuals.

 

11:30 – 12:30   Keynote lecture

                    Hubert Vidal, SFR Santé Lyon-Est, University of  Lyon, France.

                    Development of new probiotics for the treatment of diabetes/insulin resistance based on screening in Drosophila.

 

 

12:30 Lunch

 

13:30 Transfert par bus

 

 

 

 

with the support of ...                                                Avec le soutien de ...